Moreover, our results also suggested that the binding of HDL to SR-B1 on cancer cells resulted in the activation of Src, and the subsequent activation of the PI3K and MAPK/ERK pathways, indicating that these are the signals involved in the biological function of HDL in cancer cells. The gene discussed is SRC; the disease is cancer.